Innovative Capsule Filling From Molecule to Market: New Flexible Solutions for Solid Dosage Capsules
Author / Editor: Udo Comanns / Dominik Stephan
Following the rising demand for active substances processed in contained environments, Penn Pharma decided to equip its new contained manufacturing operations with a GKF HiProTect from Bosch Packaging Technology. The capsule filling machine is especially designed for processing highly potent substances and enables safe and flexible capsule manufacturing technology.
The number of potent pharmaceutical substances filled into capsules is rising at a fast pace
(Picture: Bosch Packaging Technology)
The number of potent pharmaceutical compounds requiring solid dosage development and subsequent manufacture at clinical and commercial scale is growing at a rapid pace. This process calls for contained environments to protect machine operators and products from crosscontamination.
A containment system prevents biological agents from escaping either into the working surroundings or the external environment. Containment requires closed containers or biological cabinets and the use of rooms with specially designed air handling units and secures operating procedures.
Gallery
From Molecule to Market
Penn Pharma, one of the longest established pharmaceutical services companies, sees one of its main assets as being able to operate at both a development and commercial scale. The company’s international projects have led to a significant experience in working and complying with the major regulatory bodies in Europe, the US and Japan. An important component for the company’s success is the use of state-of-the-future equipment with highest safety standards. This was also one of the main requirements when it decided to expand its production facility and started looking for a new containment capsule filling machine.
“We are seeing growth in the number of highly potent molecules coming through clinical pipelines. To meet these rising demands, we have invested in expanding our existing resources. Our vision is to become the preferred partner for the supply of solid oral doses containing potent molecules for both investigational and commercial use,” says CEO, Penn Pharma, Richard Yarwood.
"The equipment is full of innovation, which makes it a world class technology—safe, flexible and fully compliant with the demands of the global regulatory marketplace. Our customers will be delighted by the new service we can offer using the Bosch equipment.“CEO, Penn Pharma, Richard Yarwood
(Picture: Bosch Packaging Technology)
Safety Meets Flexibility
“We ran a comprehensive supplier bidding process which used over twenty different and weighted selection criteria, before shortlisting potential suppliers,” avers COO, Penn Pharma, Mark Dean-Netscher. “Owing to the very serious nature of our investment in handling highly potent drug molecules, we needed to implement an engineering solution that puts employee safety, regulatory compliance and reproductive batch scale that is central to our design philosophy,” he continues. After a number of supplier presentations, the GKF HiProTect was found to meet all these criteria.
Unfold for details of your consent
Stand vom 23.03.2021
Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.
Consent to the use of data for promotional purposes
I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planckstr. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here
Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.
In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here.
Right of revocation
I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://support.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.